Madrigal Pharmaceuticals Inc — Cash Flow (NASDAQ:MDGL) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 157.56 M183.92 M224.86 M324.23 M455.57 M189.55 M 189.55 M Cash from investing activities 159.78 M5.05 M206.69 M502.52 M274.39 M32.32 M 32.32 M Cash from financing activities 5.09 M171.24 M313.45 M595.12 M735.06 M255.98 M 255.98 M Free cash flow 157.23 M183.71 M224.64 M322.75 M449.11 M186.09 M 186.09 M

新闻

Madrigal: The Easiest Money May Have Been Made (NASDAQ:MDGL)

Novo Nordisk Stock: Why Wegovy Growth Beats Wall Street Expectations (NYSE:NVO)

H.C. Wainwright重申Madrigal Pharmaceuticals股票买入评级

H.C. Wainwright reiterates Madrigal Pharmaceuticals stock rating at buy

Madrigal Q4 Earnings Miss, MASH Drug Sales Drive Top Line, Stock Down

Lam Research, Goldman Sachs among market cap stock movers on Thursday

Madrigal Pharmaceuticals, Inc. (MDGL) Q4 2025 Earnings Call Transcript

Oracle, Deere among market cap stock movers on Thursday

Madrigal Q4 2025 slides: Rezdiffra nears $1B in first year sales despite EPS miss

Madrigal (MDGL) Reports Q4 Loss, Beats Revenue Estimates

Madrigal Pharma股价下跌超5%,第四季度盈利不及预期掩盖营收超预期表现

Madrigal Pharma shares fall over 5% as Q4 earnings miss overshadows revenue beat